The VAF distribution resembled those of known somatic mutations (p > = 0.32), including TP53 and PIK3CA mutations, but differed from those of known and identified germline mutations in these tumor samples (p < 1 × 10−6) (Fig. 3a). This evidence concerns the gene TP53 and neoplasm.